Cargando…

Actual Use of Medications Prescribed During Pregnancy: A Cross-Sectional Study Using Data from a Population-Based Congenital Anomaly Registry

INTRODUCTION AND AIM: Data from prescription databases are increasingly being used to study associations between maternal medications used in pregnancy and congenital anomalies. We therefore investigated the extent to which prescriptions reflect the actual use of medication during pregnancy, and whe...

Descripción completa

Detalles Bibliográficos
Autores principales: de Jonge, Linda, de Walle, Hermien E. K., de Jong-van den Berg, Lolkje T. W., van Langen, Irene M., Bakker, Marian K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513216/
https://www.ncbi.nlm.nih.gov/pubmed/26041497
http://dx.doi.org/10.1007/s40264-015-0302-z
_version_ 1782382609157849088
author de Jonge, Linda
de Walle, Hermien E. K.
de Jong-van den Berg, Lolkje T. W.
van Langen, Irene M.
Bakker, Marian K.
author_facet de Jonge, Linda
de Walle, Hermien E. K.
de Jong-van den Berg, Lolkje T. W.
van Langen, Irene M.
Bakker, Marian K.
author_sort de Jonge, Linda
collection PubMed
description INTRODUCTION AND AIM: Data from prescription databases are increasingly being used to study associations between maternal medications used in pregnancy and congenital anomalies. We therefore investigated the extent to which prescriptions reflect the actual use of medication during pregnancy, and whether medicines used during pregnancy are taken according to the prescribed dosage and duration. METHODS: We performed a cross-sectional study in a population-based congenital anomaly register (EUROCAT Northern Netherlands). We included 202 women who had at least one prescription during their pregnancy and who gave birth between 2009 and 2011. Compliance with the prescribed medication was verified by telephone interview. We calculated the compliance rates for several medication groups by dividing the number of mothers who confirmed they had taken the medication by the total number to whom it had been prescribed. Compliance was positive if the mother confirmed she took the medication, even if she only took one of several prescriptions from the same medication group. For each prescription taken, we also determined whether her use conformed to the prescribed dosage and duration. RESULTS: During the first trimester, the compliance rates ranged from 0.84 (for chronic diseases) to 0.92 (for pregnancy-related symptoms). Most of the medications actually taken were used at the prescribed dosage or lower. More than half of the medications actually taken were used for the duration prescribed or shorter. CONCLUSION: Prescription records are generally a relatively reliable source of data for research into associations between medication use in pregnancy and congenital anomalies compared with other data sources. Pharmacy records of medication use in pregnancy might represent an overestimation, which should be taken into account. However, our results show that, except for ‘corticosteroids, dermatological preparations’; ‘ear, eye, nose and throat preparations’; and ‘anxiolytics, hypnotics and sedatives’, this overestimation generally seems minimal. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s40264-015-0302-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4513216
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-45132162015-07-24 Actual Use of Medications Prescribed During Pregnancy: A Cross-Sectional Study Using Data from a Population-Based Congenital Anomaly Registry de Jonge, Linda de Walle, Hermien E. K. de Jong-van den Berg, Lolkje T. W. van Langen, Irene M. Bakker, Marian K. Drug Saf Original Research Article INTRODUCTION AND AIM: Data from prescription databases are increasingly being used to study associations between maternal medications used in pregnancy and congenital anomalies. We therefore investigated the extent to which prescriptions reflect the actual use of medication during pregnancy, and whether medicines used during pregnancy are taken according to the prescribed dosage and duration. METHODS: We performed a cross-sectional study in a population-based congenital anomaly register (EUROCAT Northern Netherlands). We included 202 women who had at least one prescription during their pregnancy and who gave birth between 2009 and 2011. Compliance with the prescribed medication was verified by telephone interview. We calculated the compliance rates for several medication groups by dividing the number of mothers who confirmed they had taken the medication by the total number to whom it had been prescribed. Compliance was positive if the mother confirmed she took the medication, even if she only took one of several prescriptions from the same medication group. For each prescription taken, we also determined whether her use conformed to the prescribed dosage and duration. RESULTS: During the first trimester, the compliance rates ranged from 0.84 (for chronic diseases) to 0.92 (for pregnancy-related symptoms). Most of the medications actually taken were used at the prescribed dosage or lower. More than half of the medications actually taken were used for the duration prescribed or shorter. CONCLUSION: Prescription records are generally a relatively reliable source of data for research into associations between medication use in pregnancy and congenital anomalies compared with other data sources. Pharmacy records of medication use in pregnancy might represent an overestimation, which should be taken into account. However, our results show that, except for ‘corticosteroids, dermatological preparations’; ‘ear, eye, nose and throat preparations’; and ‘anxiolytics, hypnotics and sedatives’, this overestimation generally seems minimal. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s40264-015-0302-z) contains supplementary material, which is available to authorized users. Springer International Publishing 2015-06-04 2015 /pmc/articles/PMC4513216/ /pubmed/26041497 http://dx.doi.org/10.1007/s40264-015-0302-z Text en © The Author(s) 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Research Article
de Jonge, Linda
de Walle, Hermien E. K.
de Jong-van den Berg, Lolkje T. W.
van Langen, Irene M.
Bakker, Marian K.
Actual Use of Medications Prescribed During Pregnancy: A Cross-Sectional Study Using Data from a Population-Based Congenital Anomaly Registry
title Actual Use of Medications Prescribed During Pregnancy: A Cross-Sectional Study Using Data from a Population-Based Congenital Anomaly Registry
title_full Actual Use of Medications Prescribed During Pregnancy: A Cross-Sectional Study Using Data from a Population-Based Congenital Anomaly Registry
title_fullStr Actual Use of Medications Prescribed During Pregnancy: A Cross-Sectional Study Using Data from a Population-Based Congenital Anomaly Registry
title_full_unstemmed Actual Use of Medications Prescribed During Pregnancy: A Cross-Sectional Study Using Data from a Population-Based Congenital Anomaly Registry
title_short Actual Use of Medications Prescribed During Pregnancy: A Cross-Sectional Study Using Data from a Population-Based Congenital Anomaly Registry
title_sort actual use of medications prescribed during pregnancy: a cross-sectional study using data from a population-based congenital anomaly registry
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513216/
https://www.ncbi.nlm.nih.gov/pubmed/26041497
http://dx.doi.org/10.1007/s40264-015-0302-z
work_keys_str_mv AT dejongelinda actualuseofmedicationsprescribedduringpregnancyacrosssectionalstudyusingdatafromapopulationbasedcongenitalanomalyregistry
AT dewallehermienek actualuseofmedicationsprescribedduringpregnancyacrosssectionalstudyusingdatafromapopulationbasedcongenitalanomalyregistry
AT dejongvandenberglolkjetw actualuseofmedicationsprescribedduringpregnancyacrosssectionalstudyusingdatafromapopulationbasedcongenitalanomalyregistry
AT vanlangenirenem actualuseofmedicationsprescribedduringpregnancyacrosssectionalstudyusingdatafromapopulationbasedcongenitalanomalyregistry
AT bakkermariank actualuseofmedicationsprescribedduringpregnancyacrosssectionalstudyusingdatafromapopulationbasedcongenitalanomalyregistry